nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—Heartburn—Topotecan—cervical cancer	0.00749	0.0647	CcSEcCtD
Metformin—Rigors—Topotecan—cervical cancer	0.00631	0.0546	CcSEcCtD
Metformin—Neuropathy—Topotecan—cervical cancer	0.00484	0.0418	CcSEcCtD
Metformin—Ear pain—Topotecan—cervical cancer	0.00439	0.0379	CcSEcCtD
Metformin—Lethargy—Topotecan—cervical cancer	0.00382	0.033	CcSEcCtD
Metformin—Cramp muscle—Topotecan—cervical cancer	0.00337	0.0291	CcSEcCtD
Metformin—Neutropenia—Topotecan—cervical cancer	0.00302	0.0261	CcSEcCtD
Metformin—Infestation—Topotecan—cervical cancer	0.00288	0.0249	CcSEcCtD
Metformin—Infestation NOS—Topotecan—cervical cancer	0.00288	0.0249	CcSEcCtD
Metformin—Neuropathy peripheral—Topotecan—cervical cancer	0.00283	0.0244	CcSEcCtD
Metformin—Hepatobiliary disease—Topotecan—cervical cancer	0.00273	0.0236	CcSEcCtD
Metformin—Rhinitis—Topotecan—cervical cancer	0.0026	0.0224	CcSEcCtD
Metformin—Hypoaesthesia—Topotecan—cervical cancer	0.00258	0.0223	CcSEcCtD
Metformin—Angiopathy—Topotecan—cervical cancer	0.00235	0.0203	CcSEcCtD
Metformin—Immune system disorder—Topotecan—cervical cancer	0.00234	0.0202	CcSEcCtD
Metformin—Mediastinal disorder—Topotecan—cervical cancer	0.00233	0.0202	CcSEcCtD
Metformin—Chills—Topotecan—cervical cancer	0.00232	0.0201	CcSEcCtD
Metformin—ND4—female reproductive system—cervical cancer	0.00229	0.00265	CbGeAlD
Metformin—NDUFB10—mammalian vulva—cervical cancer	0.00229	0.00265	CbGeAlD
Metformin—NDUFS4—endometrium—cervical cancer	0.00229	0.00264	CbGeAlD
Metformin—NDUFAF2—uterus—cervical cancer	0.00228	0.00264	CbGeAlD
Metformin—NDUFV1—renal system—cervical cancer	0.00228	0.00263	CbGeAlD
Metformin—NDUFB11—renal system—cervical cancer	0.00228	0.00263	CbGeAlD
Metformin—NDUFA4L2—vagina—cervical cancer	0.00227	0.00263	CbGeAlD
Metformin—NDUFB7—mammalian vulva—cervical cancer	0.00227	0.00263	CbGeAlD
Metformin—NDUFA12—mammalian vulva—cervical cancer	0.00227	0.00263	CbGeAlD
Metformin—NDUFS7—uterine cervix—cervical cancer	0.00227	0.00262	CbGeAlD
Metformin—NDUFS5—renal system—cervical cancer	0.00226	0.00262	CbGeAlD
Metformin—NDUFB8—renal system—cervical cancer	0.00226	0.00262	CbGeAlD
Metformin—NDUFB4—endometrium—cervical cancer	0.00226	0.00261	CbGeAlD
Metformin—NDUFB1—mammalian vulva—cervical cancer	0.00226	0.00261	CbGeAlD
Metformin—NDUFS8—mammalian vulva—cervical cancer	0.00226	0.00261	CbGeAlD
Metformin—Malnutrition—Topotecan—cervical cancer	0.00225	0.0195	CcSEcCtD
Metformin—NDUFV3—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.00225	0.115	CbGpPWpGaD
Metformin—NDUFAB1—endometrium—cervical cancer	0.00224	0.00259	CbGeAlD
Metformin—NDUFA2—female reproductive system—cervical cancer	0.00224	0.00259	CbGeAlD
Metformin—NDUFB9—endometrium—cervical cancer	0.00223	0.00258	CbGeAlD
Metformin—NDUFA8—endometrium—cervical cancer	0.00223	0.00258	CbGeAlD
Metformin—NDUFA11—uterus—cervical cancer	0.00223	0.00258	CbGeAlD
Metformin—NDUFB5—mammalian vulva—cervical cancer	0.00223	0.00257	CbGeAlD
Metformin—NDUFA6—mammalian vulva—cervical cancer	0.00223	0.00257	CbGeAlD
Metformin—NDUFA4—endometrium—cervical cancer	0.00221	0.00256	CbGeAlD
Metformin—NDUFAF4—uterus—cervical cancer	0.00221	0.00256	CbGeAlD
Metformin—NDUFB6—uterus—cervical cancer	0.00221	0.00256	CbGeAlD
Metformin—NDUFS4—mammalian vulva—cervical cancer	0.00221	0.00256	CbGeAlD
Metformin—NDUFB11—endometrium—cervical cancer	0.0022	0.00255	CbGeAlD
Metformin—NDUFV1—endometrium—cervical cancer	0.0022	0.00255	CbGeAlD
Metformin—NDUFS1—uterus—cervical cancer	0.00219	0.00254	CbGeAlD
Metformin—NDUFS5—endometrium—cervical cancer	0.00219	0.00253	CbGeAlD
Metformin—NDUFB8—endometrium—cervical cancer	0.00219	0.00253	CbGeAlD
Metformin—NDUFB4—mammalian vulva—cervical cancer	0.00218	0.00252	CbGeAlD
Metformin—NDUFAB1—mammalian vulva—cervical cancer	0.00217	0.00251	CbGeAlD
Metformin—Muscle spasms—Topotecan—cervical cancer	0.00217	0.0187	CcSEcCtD
Metformin—NDUFB7—uterus—cervical cancer	0.00216	0.0025	CbGeAlD
Metformin—NDUFA8—mammalian vulva—cervical cancer	0.00216	0.00249	CbGeAlD
Metformin—NDUFB9—mammalian vulva—cervical cancer	0.00216	0.00249	CbGeAlD
Metformin—ND4L—female gonad—cervical cancer	0.00215	0.00249	CbGeAlD
Metformin—ND5—female gonad—cervical cancer	0.00215	0.00249	CbGeAlD
Metformin—ND2—female gonad—cervical cancer	0.00215	0.00249	CbGeAlD
Metformin—ND3—female gonad—cervical cancer	0.00215	0.00249	CbGeAlD
Metformin—NDUFB1—uterus—cervical cancer	0.00215	0.00248	CbGeAlD
Metformin—NDUFS8—uterus—cervical cancer	0.00215	0.00248	CbGeAlD
Metformin—NDUFA4—mammalian vulva—cervical cancer	0.00214	0.00248	CbGeAlD
Metformin—NDUFA10—female reproductive system—cervical cancer	0.00214	0.00247	CbGeAlD
Metformin—NDUFB11—mammalian vulva—cervical cancer	0.00213	0.00246	CbGeAlD
Metformin—NDUFV1—mammalian vulva—cervical cancer	0.00213	0.00246	CbGeAlD
Metformin—NDUFS7—renal system—cervical cancer	0.00212	0.00245	CbGeAlD
Metformin—NDUFB5—uterus—cervical cancer	0.00212	0.00245	CbGeAlD
Metformin—NDUFA6—uterus—cervical cancer	0.00212	0.00245	CbGeAlD
Metformin—NDUFS5—mammalian vulva—cervical cancer	0.00212	0.00245	CbGeAlD
Metformin—NDUFB8—mammalian vulva—cervical cancer	0.00212	0.00245	CbGeAlD
Metformin—NDUFS4—uterus—cervical cancer	0.00211	0.00244	CbGeAlD
Metformin—NDUFB2—female reproductive system—cervical cancer	0.0021	0.00243	CbGeAlD
Metformin—Ill-defined disorder—Topotecan—cervical cancer	0.00209	0.0181	CcSEcCtD
Metformin—NDUFAF1—female reproductive system—cervical cancer	0.00208	0.00241	CbGeAlD
Metformin—ND4—female gonad—cervical cancer	0.00208	0.00241	CbGeAlD
Metformin—NDUFB4—uterus—cervical cancer	0.00208	0.0024	CbGeAlD
Metformin—PRKAB1—uterine cervix—cervical cancer	0.00207	0.0024	CbGeAlD
Metformin—ND6—female reproductive system—cervical cancer	0.00207	0.00239	CbGeAlD
Metformin—NDUFAB1—uterus—cervical cancer	0.00207	0.00239	CbGeAlD
Metformin—NDUFB3—female reproductive system—cervical cancer	0.00205	0.00237	CbGeAlD
Metformin—NDUFA4—uterus—cervical cancer	0.00204	0.00236	CbGeAlD
Metformin—NDUFA2—female gonad—cervical cancer	0.00204	0.00236	CbGeAlD
Metformin—Malaise—Topotecan—cervical cancer	0.00203	0.0176	CcSEcCtD
Metformin—NDUFV1—uterus—cervical cancer	0.00203	0.00235	CbGeAlD
Metformin—NDUFB11—uterus—cervical cancer	0.00203	0.00235	CbGeAlD
Metformin—NDUFA2—vagina—cervical cancer	0.00203	0.00234	CbGeAlD
Metformin—NDUFS5—uterus—cervical cancer	0.00202	0.00233	CbGeAlD
Metformin—NDUFB8—uterus—cervical cancer	0.00202	0.00233	CbGeAlD
Metformin—NDUFA5—female reproductive system—cervical cancer	0.002	0.00232	CbGeAlD
Metformin—NDUFA11—female reproductive system—cervical cancer	0.002	0.00232	CbGeAlD
Metformin—NDUFB6—female reproductive system—cervical cancer	0.00199	0.0023	CbGeAlD
Metformin—NDUFAF4—female reproductive system—cervical cancer	0.00199	0.0023	CbGeAlD
Metformin—PRKAB1—decidua—cervical cancer	0.00198	0.00228	CbGeAlD
Metformin—NDUFS1—female reproductive system—cervical cancer	0.00197	0.00228	CbGeAlD
Metformin—NDUFC2—epithelium—cervical cancer	0.00197	0.00228	CbGeAlD
Metformin—NDUFB10—female reproductive system—cervical cancer	0.00196	0.00227	CbGeAlD
Metformin—NDUFC2—uterine cervix—cervical cancer	0.00195	0.00226	CbGeAlD
Metformin—NDUFA10—female gonad—cervical cancer	0.00195	0.00225	CbGeAlD
Metformin—NDUFA12—female reproductive system—cervical cancer	0.00195	0.00225	CbGeAlD
Metformin—NDUFB7—female reproductive system—cervical cancer	0.00195	0.00225	CbGeAlD
Metformin—PRKAB1—renal system—cervical cancer	0.00194	0.00224	CbGeAlD
Metformin—NDUFS8—female reproductive system—cervical cancer	0.00193	0.00223	CbGeAlD
Metformin—NDUFC1—female gonad—cervical cancer	0.00193	0.00223	CbGeAlD
Metformin—Myalgia—Topotecan—cervical cancer	0.00192	0.0166	CcSEcCtD
Metformin—Chest pain—Topotecan—cervical cancer	0.00192	0.0166	CcSEcCtD
Metformin—NDUFC1—vagina—cervical cancer	0.00192	0.00222	CbGeAlD
Metformin—NDUFB2—female gonad—cervical cancer	0.00191	0.00221	CbGeAlD
Metformin—NDUFB5—female reproductive system—cervical cancer	0.00191	0.0022	CbGeAlD
Metformin—NDUFA6—female reproductive system—cervical cancer	0.00191	0.0022	CbGeAlD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00191	0.0165	CcSEcCtD
Metformin—NDUFB2—vagina—cervical cancer	0.0019	0.0022	CbGeAlD
Metformin—NDUFAF1—female gonad—cervical cancer	0.0019	0.00219	CbGeAlD
Metformin—Discomfort—Topotecan—cervical cancer	0.0019	0.0164	CcSEcCtD
Metformin—NDUFS4—female reproductive system—cervical cancer	0.00189	0.00219	CbGeAlD
Metformin—NDUFA7—lymph node—cervical cancer	0.00189	0.00219	CbGeAlD
Metformin—NDUFAF1—vagina—cervical cancer	0.00188	0.00218	CbGeAlD
Metformin—ND6—female gonad—cervical cancer	0.00188	0.00217	CbGeAlD
Metformin—NDUFS2—uterine cervix—cervical cancer	0.00188	0.00217	CbGeAlD
Metformin—PRKAB1—endometrium—cervical cancer	0.00188	0.00217	CbGeAlD
Metformin—NDUFB4—female reproductive system—cervical cancer	0.00187	0.00216	CbGeAlD
Metformin—NDUFAF2—female gonad—cervical cancer	0.00187	0.00216	CbGeAlD
Metformin—NDUFB3—female gonad—cervical cancer	0.00187	0.00216	CbGeAlD
Metformin—NDUFC2—decidua—cervical cancer	0.00186	0.00215	CbGeAlD
Metformin—NDUFAB1—female reproductive system—cervical cancer	0.00186	0.00215	CbGeAlD
Metformin—NDUFS3—uterine cervix—cervical cancer	0.00186	0.00215	CbGeAlD
Metformin—NDUFB3—vagina—cervical cancer	0.00185	0.00214	CbGeAlD
Metformin—NDUFAF2—vagina—cervical cancer	0.00185	0.00214	CbGeAlD
Metformin—NDUFA8—female reproductive system—cervical cancer	0.00185	0.00213	CbGeAlD
Metformin—NDUFB9—female reproductive system—cervical cancer	0.00185	0.00213	CbGeAlD
Metformin—NDUFA4—female reproductive system—cervical cancer	0.00183	0.00212	CbGeAlD
Metformin—NDUFC2—renal system—cervical cancer	0.00183	0.00211	CbGeAlD
Metformin—Infection—Topotecan—cervical cancer	0.00183	0.0158	CcSEcCtD
Metformin—NDUFB11—female reproductive system—cervical cancer	0.00182	0.00211	CbGeAlD
Metformin—NDUFV1—female reproductive system—cervical cancer	0.00182	0.00211	CbGeAlD
Metformin—NDUFA11—female gonad—cervical cancer	0.00182	0.00211	CbGeAlD
Metformin—NDUFA5—female gonad—cervical cancer	0.00182	0.00211	CbGeAlD
Metformin—PRKAB1—mammalian vulva—cervical cancer	0.00181	0.0021	CbGeAlD
Metformin—NDUFS5—female reproductive system—cervical cancer	0.00181	0.0021	CbGeAlD
Metformin—NDUFB8—female reproductive system—cervical cancer	0.00181	0.0021	CbGeAlD
Metformin—NDUFA5—vagina—cervical cancer	0.00181	0.00209	CbGeAlD
Metformin—NDUFA11—vagina—cervical cancer	0.00181	0.00209	CbGeAlD
Metformin—NDUFAF4—female gonad—cervical cancer	0.00181	0.00209	CbGeAlD
Metformin—NDUFB6—female gonad—cervical cancer	0.00181	0.00209	CbGeAlD
Metformin—Nervous system disorder—Topotecan—cervical cancer	0.0018	0.0156	CcSEcCtD
Metformin—Thrombocytopenia—Topotecan—cervical cancer	0.0018	0.0156	CcSEcCtD
Metformin—NDUFB6—vagina—cervical cancer	0.0018	0.00208	CbGeAlD
Metformin—NDUFAF4—vagina—cervical cancer	0.0018	0.00208	CbGeAlD
Metformin—NDUFS1—female gonad—cervical cancer	0.0018	0.00208	CbGeAlD
Metformin—NDUFS2—decidua—cervical cancer	0.00179	0.00207	CbGeAlD
Metformin—Skin disorder—Topotecan—cervical cancer	0.00179	0.0154	CcSEcCtD
Metformin—NDUFB10—female gonad—cervical cancer	0.00178	0.00206	CbGeAlD
Metformin—Hyperhidrosis—Topotecan—cervical cancer	0.00178	0.0154	CcSEcCtD
Metformin—NDUFB10—vagina—cervical cancer	0.00177	0.00205	CbGeAlD
Metformin—NDUFA12—female gonad—cervical cancer	0.00177	0.00205	CbGeAlD
Metformin—NDUFB7—female gonad—cervical cancer	0.00177	0.00205	CbGeAlD
Metformin—NDUFS3—decidua—cervical cancer	0.00177	0.00204	CbGeAlD
Metformin—NDUFC2—endometrium—cervical cancer	0.00177	0.00204	CbGeAlD
Metformin—NDUFA12—vagina—cervical cancer	0.00176	0.00203	CbGeAlD
Metformin—NDUFB7—vagina—cervical cancer	0.00176	0.00203	CbGeAlD
Metformin—NDUFS8—female gonad—cervical cancer	0.00176	0.00203	CbGeAlD
Metformin—NDUFB1—female gonad—cervical cancer	0.00176	0.00203	CbGeAlD
Metformin—NDUFS2—renal system—cervical cancer	0.00176	0.00203	CbGeAlD
Metformin—Anorexia—Topotecan—cervical cancer	0.00175	0.0152	CcSEcCtD
Metformin—NDUFB1—vagina—cervical cancer	0.00175	0.00202	CbGeAlD
Metformin—NDUFS8—vagina—cervical cancer	0.00175	0.00202	CbGeAlD
Metformin—NDUFS3—renal system—cervical cancer	0.00174	0.00201	CbGeAlD
Metformin—NDUFB5—female gonad—cervical cancer	0.00173	0.00201	CbGeAlD
Metformin—NDUFA6—female gonad—cervical cancer	0.00173	0.00201	CbGeAlD
Metformin—PRKAB1—uterus—cervical cancer	0.00173	0.002	CbGeAlD
Metformin—NDUFB5—vagina—cervical cancer	0.00172	0.00199	CbGeAlD
Metformin—NDUFA6—vagina—cervical cancer	0.00172	0.00199	CbGeAlD
Metformin—NDUFS4—female gonad—cervical cancer	0.00172	0.00199	CbGeAlD
Metformin—NDUFS4—vagina—cervical cancer	0.00171	0.00198	CbGeAlD
Metformin—NDUFC2—mammalian vulva—cervical cancer	0.00171	0.00198	CbGeAlD
Metformin—NDUFB4—female gonad—cervical cancer	0.0017	0.00197	CbGeAlD
Metformin—NDUFS2—endometrium—cervical cancer	0.0017	0.00196	CbGeAlD
Metformin—NDUFS7—female reproductive system—cervical cancer	0.0017	0.00196	CbGeAlD
Metformin—NDUFB4—vagina—cervical cancer	0.00169	0.00195	CbGeAlD
Metformin—NDUFAB1—female gonad—cervical cancer	0.00169	0.00195	CbGeAlD
Metformin—NDUFAB1—vagina—cervical cancer	0.00168	0.00194	CbGeAlD
Metformin—NDUFB9—female gonad—cervical cancer	0.00168	0.00194	CbGeAlD
Metformin—NDUFA8—female gonad—cervical cancer	0.00168	0.00194	CbGeAlD
Metformin—NDUFS3—endometrium—cervical cancer	0.00168	0.00194	CbGeAlD
Metformin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00168	0.0145	CcSEcCtD
Metformin—NDUFB9—vagina—cervical cancer	0.00167	0.00193	CbGeAlD
Metformin—NDUFA8—vagina—cervical cancer	0.00167	0.00193	CbGeAlD
Metformin—NDUFA4—female gonad—cervical cancer	0.00167	0.00193	CbGeAlD
Metformin—NDUFB11—female gonad—cervical cancer	0.00166	0.00192	CbGeAlD
Metformin—NDUFV1—female gonad—cervical cancer	0.00166	0.00192	CbGeAlD
Metformin—NDUFA4—vagina—cervical cancer	0.00166	0.00192	CbGeAlD
Metformin—Paraesthesia—Topotecan—cervical cancer	0.00165	0.0143	CcSEcCtD
Metformin—NDUFB8—female gonad—cervical cancer	0.00165	0.00191	CbGeAlD
Metformin—NDUFS5—female gonad—cervical cancer	0.00165	0.00191	CbGeAlD
Metformin—NDUFV1—vagina—cervical cancer	0.00165	0.00191	CbGeAlD
Metformin—NDUFB11—vagina—cervical cancer	0.00165	0.00191	CbGeAlD
Metformin—NDUFS2—mammalian vulva—cervical cancer	0.00164	0.0019	CbGeAlD
Metformin—Dyspnoea—Topotecan—cervical cancer	0.00164	0.0142	CcSEcCtD
Metformin—NDUFB8—vagina—cervical cancer	0.00164	0.0019	CbGeAlD
Metformin—NDUFS5—vagina—cervical cancer	0.00164	0.0019	CbGeAlD
Metformin—NDUFC2—uterus—cervical cancer	0.00163	0.00188	CbGeAlD
Metformin—NDUFS3—mammalian vulva—cervical cancer	0.00162	0.00188	CbGeAlD
Metformin—Dyspepsia—Topotecan—cervical cancer	0.00162	0.014	CcSEcCtD
Metformin—Decreased appetite—Topotecan—cervical cancer	0.0016	0.0138	CcSEcCtD
Metformin—Gastrointestinal disorder—Topotecan—cervical cancer	0.00159	0.0137	CcSEcCtD
Metformin—Fatigue—Topotecan—cervical cancer	0.00159	0.0137	CcSEcCtD
Metformin—Constipation—Topotecan—cervical cancer	0.00157	0.0136	CcSEcCtD
Metformin—NDUFS2—uterus—cervical cancer	0.00157	0.00181	CbGeAlD
Metformin—PRKAB1—female reproductive system—cervical cancer	0.00155	0.0018	CbGeAlD
Metformin—NDUFS3—uterus—cervical cancer	0.00155	0.00179	CbGeAlD
Metformin—NDUFS7—female gonad—cervical cancer	0.00155	0.00179	CbGeAlD
Metformin—NDUFS7—vagina—cervical cancer	0.00154	0.00178	CbGeAlD
Metformin—Feeling abnormal—Topotecan—cervical cancer	0.00152	0.0131	CcSEcCtD
Metformin—NDUFV2—lymph node—cervical cancer	0.00151	0.00175	CbGeAlD
Metformin—Gastrointestinal pain—Topotecan—cervical cancer	0.0015	0.013	CcSEcCtD
Metformin—NDUFA4L2—lymph node—cervical cancer	0.00147	0.0017	CbGeAlD
Metformin—NDUFC2—female reproductive system—cervical cancer	0.00146	0.00169	CbGeAlD
Metformin—Urticaria—Topotecan—cervical cancer	0.00146	0.0126	CcSEcCtD
Metformin—Abdominal pain—Topotecan—cervical cancer	0.00145	0.0126	CcSEcCtD
Metformin—ND1—renal system—cervical cancer	0.00144	0.00167	CbGeAlD
Metformin—PRKAB1—female gonad—cervical cancer	0.00141	0.00163	CbGeAlD
Metformin—NDUFS2—female reproductive system—cervical cancer	0.00141	0.00163	CbGeAlD
Metformin—PRKAB1—vagina—cervical cancer	0.0014	0.00162	CbGeAlD
Metformin—NDUFS3—female reproductive system—cervical cancer	0.00139	0.00161	CbGeAlD
Metformin—ND4L—lymph node—cervical cancer	0.00138	0.0016	CbGeAlD
Metformin—ND3—lymph node—cervical cancer	0.00138	0.0016	CbGeAlD
Metformin—ND5—lymph node—cervical cancer	0.00138	0.0016	CbGeAlD
Metformin—ND2—lymph node—cervical cancer	0.00138	0.0016	CbGeAlD
Metformin—ND4—lymph node—cervical cancer	0.00134	0.00155	CbGeAlD
Metformin—NDUFC2—female gonad—cervical cancer	0.00133	0.00154	CbGeAlD
Metformin—NDUFC2—vagina—cervical cancer	0.00132	0.00153	CbGeAlD
Metformin—Asthenia—Topotecan—cervical cancer	0.00132	0.0114	CcSEcCtD
Metformin—NDUFA2—lymph node—cervical cancer	0.00131	0.00152	CbGeAlD
Metformin—Pruritus—Topotecan—cervical cancer	0.0013	0.0112	CcSEcCtD
Metformin—NDUFS2—female gonad—cervical cancer	0.00128	0.00148	CbGeAlD
Metformin—NDUFS2—vagina—cervical cancer	0.00127	0.00147	CbGeAlD
Metformin—NDUFS3—female gonad—cervical cancer	0.00126	0.00146	CbGeAlD
Metformin—Diarrhoea—Topotecan—cervical cancer	0.00126	0.0109	CcSEcCtD
Metformin—NDUFS3—vagina—cervical cancer	0.00126	0.00145	CbGeAlD
Metformin—NDUFA10—lymph node—cervical cancer	0.00125	0.00145	CbGeAlD
Metformin—NDUFC1—lymph node—cervical cancer	0.00124	0.00143	CbGeAlD
Metformin—NDUFB2—lymph node—cervical cancer	0.00123	0.00142	CbGeAlD
Metformin—NDUFAF1—lymph node—cervical cancer	0.00122	0.00141	CbGeAlD
Metformin—Dizziness—Topotecan—cervical cancer	0.00122	0.0105	CcSEcCtD
Metformin—ND6—lymph node—cervical cancer	0.00121	0.0014	CbGeAlD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—PIAS3—cervical cancer	0.0012	0.0615	CbGpPWpGaD
Metformin—NDUFB3—lymph node—cervical cancer	0.0012	0.00139	CbGeAlD
Metformin—NDUFAF2—lymph node—cervical cancer	0.0012	0.00139	CbGeAlD
Metformin—NDUFA5—lymph node—cervical cancer	0.00117	0.00135	CbGeAlD
Metformin—NDUFA11—lymph node—cervical cancer	0.00117	0.00135	CbGeAlD
Metformin—Vomiting—Topotecan—cervical cancer	0.00117	0.0101	CcSEcCtD
Metformin—NDUFAF4—lymph node—cervical cancer	0.00116	0.00134	CbGeAlD
Metformin—NDUFB6—lymph node—cervical cancer	0.00116	0.00134	CbGeAlD
Metformin—Rash—Topotecan—cervical cancer	0.00116	0.01	CcSEcCtD
Metformin—Dermatitis—Topotecan—cervical cancer	0.00116	0.01	CcSEcCtD
Metformin—SLC22A2—renal system—cervical cancer	0.00116	0.00134	CbGeAlD
Metformin—ND1—female reproductive system—cervical cancer	0.00115	0.00134	CbGeAlD
Metformin—NDUFS1—lymph node—cervical cancer	0.00115	0.00133	CbGeAlD
Metformin—Headache—Topotecan—cervical cancer	0.00115	0.00996	CcSEcCtD
Metformin—NDUFB10—lymph node—cervical cancer	0.00115	0.00133	CbGeAlD
Metformin—NDUFB7—lymph node—cervical cancer	0.00114	0.00132	CbGeAlD
Metformin—NDUFA12—lymph node—cervical cancer	0.00114	0.00132	CbGeAlD
Metformin—NDUFB1—lymph node—cervical cancer	0.00113	0.00131	CbGeAlD
Metformin—NDUFS8—lymph node—cervical cancer	0.00113	0.00131	CbGeAlD
Metformin—NDUFB5—lymph node—cervical cancer	0.00111	0.00129	CbGeAlD
Metformin—NDUFA6—lymph node—cervical cancer	0.00111	0.00129	CbGeAlD
Metformin—NDUFS4—lymph node—cervical cancer	0.00111	0.00128	CbGeAlD
Metformin—NDUFB4—lymph node—cervical cancer	0.00109	0.00126	CbGeAlD
Metformin—Nausea—Topotecan—cervical cancer	0.00109	0.00944	CcSEcCtD
Metformin—NDUFAF2—Validated targets of C-MYC transcriptional activation—TERT—cervical cancer	0.00109	0.0559	CbGpPWpGaD
Metformin—NDUFAB1—lymph node—cervical cancer	0.00109	0.00126	CbGeAlD
Metformin—NDUFA8—lymph node—cervical cancer	0.00108	0.00125	CbGeAlD
Metformin—NDUFB9—lymph node—cervical cancer	0.00108	0.00125	CbGeAlD
Metformin—NDUFA4—lymph node—cervical cancer	0.00107	0.00124	CbGeAlD
Metformin—NDUFV1—lymph node—cervical cancer	0.00107	0.00123	CbGeAlD
Metformin—NDUFB11—lymph node—cervical cancer	0.00107	0.00123	CbGeAlD
Metformin—NDUFS5—lymph node—cervical cancer	0.00106	0.00123	CbGeAlD
Metformin—NDUFB8—lymph node—cervical cancer	0.00106	0.00123	CbGeAlD
Metformin—ND1—female gonad—cervical cancer	0.00105	0.00121	CbGeAlD
Metformin—SLC47A1—uterine cervix—cervical cancer	0.00105	0.00121	CbGeAlD
Metformin—SLC47A1—decidua—cervical cancer	0.000997	0.00115	CbGeAlD
Metformin—NDUFS7—lymph node—cervical cancer	0.000994	0.00115	CbGeAlD
Metformin—SLC47A1—renal system—cervical cancer	0.000979	0.00113	CbGeAlD
Metformin—SLC47A1—endometrium—cervical cancer	0.000947	0.00109	CbGeAlD
Metformin—SLC47A1—mammalian vulva—cervical cancer	0.000916	0.00106	CbGeAlD
Metformin—PRKAB1—lymph node—cervical cancer	0.000909	0.00105	CbGeAlD
Metformin—PRKAB1—SREBP signalling—YY1—cervical cancer	0.000897	0.046	CbGpPWpGaD
Metformin—SLC47A1—uterus—cervical cancer	0.000873	0.00101	CbGeAlD
Metformin—NDUFC2—lymph node—cervical cancer	0.000856	0.00099	CbGeAlD
Metformin—SLC22A3—uterine cervix—cervical cancer	0.000835	0.000965	CbGeAlD
Metformin—NDUFS2—lymph node—cervical cancer	0.000823	0.000952	CbGeAlD
Metformin—SLC22A1—renal system—cervical cancer	0.000817	0.000945	CbGeAlD
Metformin—NDUFS3—lymph node—cervical cancer	0.000813	0.00094	CbGeAlD
Metformin—SLC47A1—female reproductive system—cervical cancer	0.000784	0.000907	CbGeAlD
Metformin—SLC22A3—renal system—cervical cancer	0.000781	0.000903	CbGeAlD
Metformin—SLC22A3—endometrium—cervical cancer	0.000755	0.000873	CbGeAlD
Metformin—SLC22A3—mammalian vulva—cervical cancer	0.00073	0.000845	CbGeAlD
Metformin—SLC47A1—female gonad—cervical cancer	0.000714	0.000825	CbGeAlD
Metformin—SLC47A1—vagina—cervical cancer	0.000709	0.00082	CbGeAlD
Metformin—NDUFA13—NOD pathway—CASP8—cervical cancer	0.000707	0.0362	CbGpPWpGaD
Metformin—ND1—lymph node—cervical cancer	0.000675	0.000781	CbGeAlD
Metformin—SLC22A3—female reproductive system—cervical cancer	0.000625	0.000723	CbGeAlD
Metformin—PRKAB1—Direct p53 effectors—POU4F1—cervical cancer	0.000608	0.0311	CbGpPWpGaD
Metformin—SLC22A1—vagina—cervical cancer	0.000592	0.000684	CbGeAlD
Metformin—SLC22A3—female gonad—cervical cancer	0.000569	0.000658	CbGeAlD
Metformin—SLC22A3—vagina—cervical cancer	0.000566	0.000654	CbGeAlD
Metformin—SLC47A1—lymph node—cervical cancer	0.000459	0.000531	CbGeAlD
Metformin—NDUFAF2—Validated targets of C-MYC transcriptional activation—TP53—cervical cancer	0.000416	0.0213	CbGpPWpGaD
Metformin—PRKAB1—mTOR signalling—MTOR—cervical cancer	0.000366	0.0188	CbGpPWpGaD
Metformin—SLC22A3—lymph node—cervical cancer	0.000366	0.000423	CbGeAlD
Metformin—PRKAB1—PKB-mediated events—MTOR—cervical cancer	0.000356	0.0182	CbGpPWpGaD
Metformin—PRKAB1—TOR Signaling—MTOR—cervical cancer	0.000291	0.0149	CbGpPWpGaD
Metformin—PRKAB1—PI3K Cascade—FGFR3—cervical cancer	0.000249	0.0127	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—FGFR3—cervical cancer	0.000208	0.0107	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—FGFR3—cervical cancer	0.000202	0.0104	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—FGFR3—cervical cancer	0.0002	0.0103	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—FGFR3—cervical cancer	0.000195	0.01	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—FGFR3—cervical cancer	0.000195	0.01	CbGpPWpGaD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	0.000194	0.00992	CbGpPWpGaD
Metformin—PRKAB1—PI3K Cascade—MTOR—cervical cancer	0.000175	0.00896	CbGpPWpGaD
Metformin—PRKAB1—AMPK Signaling—MTOR—cervical cancer	0.000173	0.00885	CbGpPWpGaD
Metformin—PRKAB1—SREBP signalling—MTOR—cervical cancer	0.000173	0.00885	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—FGFR3—cervical cancer	0.000162	0.0083	CbGpPWpGaD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	0.00015	0.00767	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—MTOR—cervical cancer	0.000146	0.00749	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—MTOR—cervical cancer	0.000142	0.00729	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—CA9—cervical cancer	0.000142	0.00728	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—MTOR—cervical cancer	0.000141	0.00722	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—MTOR—cervical cancer	0.000137	0.00703	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—MTOR—cervical cancer	0.000137	0.00703	CbGpPWpGaD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	0.000136	0.00697	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—CA9—cervical cancer	0.00013	0.00666	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—CA9—cervical cancer	0.00013	0.00666	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—CA9—cervical cancer	0.00013	0.00666	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—CA9—cervical cancer	0.00013	0.00666	CbGpPWpGaD
Metformin—ND2—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—ND6—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—ND5—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—ND4L—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—ND4—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—ND3—Metabolism—CA9—cervical cancer	0.000121	0.00619	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—MTOR—cervical cancer	0.000114	0.00584	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—CA9—cervical cancer	0.000108	0.00552	CbGpPWpGaD
Metformin—PRKAB1—AMPK Signaling—TP53—cervical cancer	0.000102	0.00522	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—CA9—cervical cancer	9.16e-05	0.00469	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—CA9—cervical cancer	9.16e-05	0.00469	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—CA9—cervical cancer	9.16e-05	0.00469	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—CA9—cervical cancer	8.61e-05	0.00441	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—EGFR—cervical cancer	6.89e-05	0.00353	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TAAR6—cervical cancer	6.18e-05	0.00317	CbGpPWpGaD
Metformin—ND1—Metabolism—CA9—cervical cancer	5.9e-05	0.00302	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—TP53—cervical cancer	5.79e-05	0.00296	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—MTHFR—cervical cancer	5.77e-05	0.00296	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—MTHFR—cervical cancer	5.28e-05	0.0027	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—MTHFR—cervical cancer	5.28e-05	0.0027	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—MTHFR—cervical cancer	5.28e-05	0.0027	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—MTHFR—cervical cancer	5.28e-05	0.0027	CbGpPWpGaD
Metformin—ND6—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—ND4—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—ND2—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—ND4L—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—ND5—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—ND3—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—MTHFR—cervical cancer	4.91e-05	0.00251	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—WNT2—cervical cancer	4.82e-05	0.00247	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—MTHFR—cervical cancer	4.37e-05	0.00224	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKAP13—cervical cancer	4.24e-05	0.00217	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—MTHFR—cervical cancer	3.72e-05	0.0019	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—MTHFR—cervical cancer	3.72e-05	0.0019	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—MTHFR—cervical cancer	3.72e-05	0.0019	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—WNT5A—cervical cancer	3.66e-05	0.00187	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—MTHFR—cervical cancer	3.5e-05	0.00179	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CA9—cervical cancer	2.75e-05	0.00141	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH2—cervical cancer	2.57e-05	0.00131	CbGpPWpGaD
Metformin—ND1—Metabolism—MTHFR—cervical cancer	2.4e-05	0.00123	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HES1—cervical cancer	2.1e-05	0.00108	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TERT—cervical cancer	1.84e-05	0.000944	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CA9—cervical cancer	1.73e-05	0.000884	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGFR3—cervical cancer	1.69e-05	0.000867	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CA9—cervical cancer	1.61e-05	0.000824	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH1—cervical cancer	1.59e-05	0.000814	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MTOR—cervical cancer	1.19e-05	0.00061	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—MTHFR—cervical cancer	1.12e-05	0.000572	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—cervical cancer	1.09e-05	0.000561	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CTNNB1—cervical cancer	1.06e-05	0.00054	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—cervical cancer	9.2e-06	0.000471	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—cervical cancer	8.36e-06	0.000428	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—cervical cancer	7.02e-06	0.00036	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTHFR—cervical cancer	7e-06	0.000359	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTHFR—cervical cancer	6.52e-06	0.000334	CbGpPWpGaD
